403 related articles for article (PubMed ID: 29939815)
1. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data.
Bor R; Fábián A; Farkas K; Molnár T; Szepes Z
Expert Opin Biol Ther; 2018 Jul; 18(7):737-745. PubMed ID: 29939815
[TBL] [Abstract][Full Text] [Related]
2. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cells for Perianal Crohn's Disease.
Carvello M; Lightner A; Yamamoto T; Kotze PG; Spinelli A
Cells; 2019 Jul; 8(7):. PubMed ID: 31340546
[TBL] [Abstract][Full Text] [Related]
4. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
Meng ZW; Baumgart DC
Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
[TBL] [Abstract][Full Text] [Related]
6. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
Hawkey CJ; Hommes DW
Gastroenterology; 2017 Feb; 152(2):389-397.e2. PubMed ID: 27845055
[TBL] [Abstract][Full Text] [Related]
7. TRANSPLANTATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN REFRACTORY CROHN'S DISEASE: SYSTEMATIC REVIEW.
Bernardi L; Santos CHMD; Pinheiro VAZ; Oliveira RJ; Antoniolli-Silva ACMB
Arq Bras Cir Dig; 2019; 32(4):e1465. PubMed ID: 31859918
[TBL] [Abstract][Full Text] [Related]
8. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease.
Bislenghi G; Wolthuis A; Van Assche G; Vermeire S; Ferrante M; D'Hoore A
Expert Opin Biol Ther; 2019 Jul; 19(7):607-616. PubMed ID: 31121104
[No Abstract] [Full Text] [Related]
9. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
Cheng F; Huang Z; Li Z
Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
[TBL] [Abstract][Full Text] [Related]
10. Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.
Panés J; Rimola J
Nat Rev Gastroenterol Hepatol; 2017 Nov; 14(11):652-664. PubMed ID: 28790453
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn's Disease: An Up-To-Date Review.
Gallo G; Tiesi V; Fulginiti S; De Paola G; Vescio G; Sammarco G
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33121049
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.
Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V
Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
Ko JZ; Johnson S; Dave M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell Therapy for the Treatment of Crohn's Disease; Current Obstacles and Future Hopes.
El-Nakeep S
Curr Stem Cell Res Ther; 2022; 17(8):727-733. PubMed ID: 34514993
[TBL] [Abstract][Full Text] [Related]
16. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T
Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
[TBL] [Abstract][Full Text] [Related]
17. Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study.
Reenaers C; Gillard RP; Coimbra C; Gillard RM; Meunier P; Lechanteur C; Baudoux E; Boutaffala L; Beguin Y; Louis É
J Crohns Colitis; 2023 May; 17(5):728-737. PubMed ID: 36733215
[TBL] [Abstract][Full Text] [Related]
18. Spatio-Temporal Metabolokinetics and Efficacy of Human Placenta-Derived Mesenchymal Stem/Stromal Cells on Mice with Refractory Crohn's-like Enterocutaneous Fistula.
Hou H; Zhang L; Duan L; Liu Y; Han Z; Li Z; Cao X
Stem Cell Rev Rep; 2020 Dec; 16(6):1292-1304. PubMed ID: 33011925
[TBL] [Abstract][Full Text] [Related]
19. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
[TBL] [Abstract][Full Text] [Related]
20. Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.
Ibraheim H; Giacomini C; Kassam Z; Dazzi F; Powell N
Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):141-153. PubMed ID: 29096549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
